Ligand Pharma

$126.61 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About Ligand Pharma

Ligand Pharmaceuticals Incorporated (Ligand) is a biopharmaceutical company that focuses on developing and acquiring technologies that help pharmaceutical companies discover and develop medicines. The Company is involved in the development and licensing of biopharmaceutical assets. The Company employs research technologies, such as nuclear receptor assays, high throughput computer screening, formulation science, liver targeted pro-drug technologies and antibody discovery technologies to assist companies in their work toward obtaining prescription drug approvals. As of December 31, 2016, it had partnerships and license agreements with over 85 pharmaceutical and biotechnology companies, and over 140 various programs under license with it were in various stages of commercialization and development. It has contributed research and technologies for approved medicines that treat cancer, osteoporosis, fungal infections and low blood platelets, among others.

Stock Analysis

last close $123.82
1-mo return -4.4%
3-mo return -24.1%
avg daily vol. 154.31T
52-week high 219.75
52-week low 78.26
market cap. $2.1B
forward pe 22.1
annual div. -
roe 5.6%
ltg forecast 19.2%
dividend yield -
annual rev. $208M
inst own. 95.9%
baraka

Subscribe now for daily local and international financial news

Subscribe